SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-004515
Filing Date
2023-03-08
Accepted
2023-03-08 18:01:03
Documents
2
Period of Report
2023-03-07

Document Format Files

Seq Description Document Type Size
1 form3-03082023_110357.html 3  
1 form3-03082023_110357.xml 3 6486
2 ex24-03082023_110300.htm EX-24 8350
  Complete submission text file 0001415889-23-004515.txt   16219
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AEROVATE THERAPEUTICS, INC. 930 WINTER STREET, SUITE M-500 WALTHAM MA 02451
Business Address
Pigot Timothy (Reporting) CIK: 0001967140 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40544 | Film No.: 23717482